Eppendorf AG, a leading name in the life sciences industry, is headquartered in Hamburg, Germany (DE). Founded in 1945, the company has established itself as a pioneer in laboratory equipment and consumables, serving researchers and scientists across the globe. Eppendorf's core business areas include liquid handling, sample handling, and cell culture, with innovative products such as pipettes, centrifuges, and bioreactors that are renowned for their precision and reliability. With a strong presence in Europe, North America, and Asia, Eppendorf has achieved significant milestones, including numerous awards for product excellence and sustainability initiatives. The company is committed to advancing scientific research, making it a trusted partner in laboratories worldwide. Eppendorf's dedication to quality and innovation solidifies its position as a market leader in the life sciences sector.
How does Eppendorf's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Eppendorf's score of 38 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Eppendorf SE reported total carbon emissions of approximately 700,900 kg CO2e from Scope 1, 1,805,000 kg CO2e from Scope 2 (market-based), and significant Scope 3 emissions, including 2,256,000 kg CO2e from business travel and 246,561,000 kg CO2e from the use of sold products. The total emissions from Scope 1 and 2 combined were about 8,814,000 kg CO2e. Eppendorf has set ambitious climate commitments, aiming to achieve net-zero emissions for its Scope 1 and 2 operations by 2028, using 2019 as the baseline year. This target represents a reduction of about 1% from their 2019 emissions levels. Furthermore, the company has committed to reducing its absolute Scope 1 and 2 greenhouse gas emissions by 63% by 2035 from a 2023 base year, alongside a similar reduction target for Scope 3 emissions related to purchased goods, capital goods, and the use of sold products. Eppendorf's climate initiatives are aligned with industry standards, and they are actively working towards these targets without cascading data from a parent organization. The company is committed to transparency and accountability in its sustainability efforts, reflecting its dedication to reducing its carbon footprint in the pharmaceuticals, biotechnology, and life sciences sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 7,644,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,202,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 86,074,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Eppendorf's Scope 3 emissions, which increased by 6% last year and increased by approximately 196% since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 97% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eppendorf has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Eppendorf's sustainability data and climate commitments